Lucca A, Lucini V, Catalano M, Alfano M, Smeraldi E
Istituto di Ricovero e Cura a Carattere Scientifico H. San Raffaele, Italia.
Neuropsychobiology. 1994;29(3):108-11. doi: 10.1159/000119071.
The molar ratio of total plasma tryptophan (Trp) to the sum of the other large neutral amino acids (LNAAs), thought to reflect brain serotonin (5-HT) formation, was estimated in 47 patients with major depression (unipolar and bipolar) before and after 6 weeks of treatment with a serotonin uptake inhibitor, fluvoxamine. We found a significant difference between responders (n = 39) and nonresponders (n = 8) for the pre- and in-treatment plasma Trp to LNAAs ratios. In contrast, there were no differences between the two groups for the mean plasma steady-state fluvoxamine levels. These findings suggest that a specific plasma amino acid profile may be a useful indicator of good clinical response to a selective 5-HT uptake inhibitor.
在47例重度抑郁症(单相和双相)患者中,在使用血清素摄取抑制剂氟伏沙明治疗6周之前和之后,估计了总血浆色氨酸(Trp)与其他大中性氨基酸(LNAAs)总和的摩尔比,该比值被认为反映了脑血清素(5-HT)的形成。我们发现,治疗前和治疗期间血浆Trp与LNAAs比值在反应者(n = 39)和无反应者(n = 8)之间存在显著差异。相比之下,两组之间的平均血浆稳态氟伏沙明水平没有差异。这些发现表明,特定的血浆氨基酸谱可能是对选择性5-HT摄取抑制剂产生良好临床反应的有用指标。